Annual FCF
$11.71 B
-$292.00 M-2.43%
31 December 2023
Summary:
Novartis AG annual free cash flow is currently $11.71 billion, with the most recent change of -$292.00 million (-2.43%) on 31 December 2023. During the last 3 years, it has risen by +$640.00 million (+5.78%). NVS annual FCF is now -6.47% below its all-time high of $12.52 billion, reached on 31 December 2021.NVS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$5.49 B
+$1.34 B+32.31%
30 September 2024
Summary:
Novartis AG quarterly free cash flow is currently $5.49 billion, with the most recent change of +$1.34 billion (+32.31%) on 30 September 2024. Over the past year, it has increased by +$792.00 million (+16.87%). NVS quarterly FCF is now -42.48% below its all-time high of $9.54 billion, reached on 30 September 2007.NVS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$12.51 B
+$792.00 M+6.76%
30 September 2024
Summary:
Novartis AG TTM free cash flow is currently $12.51 billion, with the most recent change of +$792.00 million (+6.76%) on 30 September 2024. Over the past year, it has dropped by -$1.05 billion (-7.72%). NVS TTM FCF is now -9.21% below its all-time high of $13.78 billion, reached on 31 March 2023.NVS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.4% | +16.9% | -7.7% |
| 3 y3 years | +5.8% | +25.1% | +2.7% |
| 5 y5 years | +0.7% | +37.2% | +8.0% |
NVS Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.5% | +5.8% | at high | +594.6% | -9.2% | +22.1% |
| 5 y | 5 years | -6.5% | +5.8% | at high | +594.6% | -9.2% | +22.1% |
| alltime | all time | -6.5% | +293.2% | -42.5% | +186.3% | -9.2% | +927.7% |
Novartis AG Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.49 B(+32.3%) | $12.51 B(+6.8%) |
| June 2024 | - | $4.15 B(+273.9%) | $11.71 B(+14.3%) |
| Mar 2024 | - | $1.11 B(-37.1%) | $10.25 B(-12.5%) |
| Dec 2023 | $11.71 B(-2.4%) | $1.76 B(-62.4%) | $11.71 B(-13.6%) |
| Sept 2023 | - | $4.70 B(+75.3%) | $13.55 B(+2.1%) |
| June 2023 | - | $2.68 B(+4.3%) | $13.28 B(-3.6%) |
| Mar 2023 | - | $2.57 B(-28.9%) | $13.78 B(+14.8%) |
| Dec 2022 | $12.00 B(-4.1%) | $3.61 B(-18.3%) | $12.00 B(+2.5%) |
| Sept 2022 | - | $4.42 B(+39.4%) | $11.71 B(+0.3%) |
| June 2022 | - | $3.17 B(+301.5%) | $11.67 B(-3.0%) |
| Mar 2022 | - | $790.00 M(-76.2%) | $12.03 B(-3.9%) |
| Dec 2021 | $12.52 B(+13.1%) | $3.32 B(-24.3%) | $12.52 B(+2.8%) |
| Sept 2021 | - | $4.39 B(+24.1%) | $12.18 B(+18.0%) |
| June 2021 | - | $3.54 B(+177.9%) | $10.32 B(+0.3%) |
| Mar 2021 | - | $1.27 B(-57.3%) | $10.29 B(-7.0%) |
| Dec 2020 | $11.06 B(-2.7%) | $2.98 B(+17.9%) | $11.06 B(+0.7%) |
| Sept 2020 | - | $2.53 B(-27.9%) | $10.99 B(-11.8%) |
| June 2020 | - | $3.51 B(+71.6%) | $12.46 B(+8.7%) |
| Mar 2020 | - | $2.04 B(-29.6%) | $11.46 B(+0.8%) |
| Dec 2019 | $11.37 B(-2.2%) | $2.90 B(-27.4%) | $11.37 B(-1.8%) |
| Sept 2019 | - | $4.00 B(+59.6%) | $11.58 B(+7.3%) |
| June 2019 | - | $2.51 B(+28.1%) | $10.79 B(-8.1%) |
| Mar 2019 | - | $1.96 B(-37.2%) | $11.74 B(+1.0%) |
| Dec 2018 | $11.62 B(+12.6%) | $3.12 B(-2.9%) | $11.62 B(+2.0%) |
| Sept 2018 | - | $3.21 B(-7.2%) | $11.40 B(+2.6%) |
| June 2018 | - | $3.46 B(+88.0%) | $11.11 B(+4.0%) |
| Mar 2018 | - | $1.84 B(-36.3%) | $10.68 B(+3.4%) |
| Dec 2017 | $10.33 B(+20.1%) | $2.89 B(-0.9%) | $10.33 B(+0.8%) |
| Sept 2017 | - | $2.92 B(-3.7%) | $10.25 B(+4.1%) |
| June 2017 | - | $3.03 B(+103.2%) | $9.85 B(+6.4%) |
| Mar 2017 | - | $1.49 B(-46.9%) | $9.25 B(+7.7%) |
| Dec 2016 | $8.60 B(+2.4%) | $2.81 B(+11.6%) | $8.60 B(-4.2%) |
| Sept 2016 | - | $2.52 B(+3.3%) | $8.97 B(+1.9%) |
| June 2016 | - | $2.44 B(+192.4%) | $8.80 B(+6.9%) |
| Mar 2016 | - | $833.00 M(-73.9%) | $8.24 B(-1.9%) |
| Dec 2015 | $8.39 B(-20.0%) | $3.19 B(+35.9%) | $8.39 B(-12.3%) |
| Sept 2015 | - | $2.35 B(+25.6%) | $9.57 B(-6.5%) |
| June 2015 | - | $1.87 B(+88.9%) | $10.24 B(-4.7%) |
| Mar 2015 | - | $989.00 M(-77.4%) | $10.75 B(+2.4%) |
| Dec 2014 | $10.49 B(+7.1%) | $4.37 B(+45.1%) | $10.49 B(+10.5%) |
| Sept 2014 | - | $3.01 B(+26.7%) | $9.50 B(-4.9%) |
| June 2014 | - | $2.38 B(+224.4%) | $9.98 B(+6.8%) |
| Mar 2014 | - | $733.00 M(-78.3%) | $9.35 B(-4.5%) |
| Dec 2013 | $9.80 B | $3.37 B(-3.6%) | $9.80 B(-5.5%) |
| Sept 2013 | - | $3.50 B(+100.7%) | $10.37 B(+1.9%) |
| June 2013 | - | $1.74 B(+48.0%) | $10.18 B(-4.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $1.18 B(-70.2%) | $10.71 B(-6.3%) |
| Dec 2012 | $11.42 B(-4.2%) | $3.95 B(+19.2%) | $11.42 B(-0.9%) |
| Sept 2012 | - | $3.31 B(+45.8%) | $11.52 B(-2.9%) |
| June 2012 | - | $2.27 B(+20.0%) | $11.86 B(-4.4%) |
| Mar 2012 | - | $1.89 B(-53.3%) | $12.41 B(+4.1%) |
| Dec 2011 | $11.92 B(+0.7%) | $4.05 B(+10.9%) | $11.92 B(+1.8%) |
| Sept 2011 | - | $3.65 B(+29.3%) | $11.71 B(+7.5%) |
| June 2011 | - | $2.82 B(+101.4%) | $10.89 B(+5.0%) |
| Mar 2011 | - | $1.40 B(-63.4%) | $10.38 B(-12.3%) |
| Dec 2010 | $11.84 B(+25.1%) | $3.83 B(+35.2%) | $11.84 B(+3.1%) |
| Sept 2010 | - | $2.83 B(+22.8%) | $11.47 B(+1.7%) |
| June 2010 | - | $2.31 B(-19.3%) | $11.28 B(+3.8%) |
| Mar 2010 | - | $2.86 B(-17.7%) | $10.87 B(+14.9%) |
| Dec 2009 | $9.46 B(+26.9%) | $3.47 B(+31.6%) | $9.46 B(+10.0%) |
| Sept 2009 | - | $2.64 B(+38.9%) | $8.60 B(+2.4%) |
| June 2009 | - | $1.90 B(+31.1%) | $8.39 B(+10.9%) |
| Mar 2009 | - | $1.45 B(-44.5%) | $7.57 B(+1.5%) |
| Dec 2008 | $7.45 B(+22.6%) | $2.61 B(+7.1%) | $7.45 B(-593.2%) |
| Sept 2008 | - | $2.44 B(+127.5%) | -$1.51 B(-127.0%) |
| June 2008 | - | $1.07 B(-19.9%) | $5.59 B(-3.5%) |
| Mar 2008 | - | $1.34 B(-121.0%) | $5.80 B(-4.6%) |
| Dec 2007 | $6.08 B(+0.0%) | -$6.36 B(-166.6%) | $6.08 B(-53.9%) |
| Sept 2007 | - | $9.54 B(+648.8%) | $13.19 B(+134.1%) |
| June 2007 | - | $1.27 B(-21.3%) | $5.63 B(-0.2%) |
| Mar 2007 | - | $1.62 B(+114.9%) | $5.64 B(-7.1%) |
| Dec 2006 | $6.07 B(-4.6%) | $753.00 M(-62.1%) | $6.07 B(-8.6%) |
| Sept 2006 | - | $1.99 B(+54.9%) | $6.65 B(-3.8%) |
| June 2006 | - | $1.28 B(-37.4%) | $6.91 B(+3.3%) |
| Mar 2006 | - | $2.05 B(+54.7%) | $6.68 B(+4.9%) |
| Dec 2005 | $6.37 B(+24.3%) | $1.32 B(-41.1%) | $6.37 B(+3.0%) |
| Sept 2005 | - | $2.25 B(+111.7%) | $6.19 B(+8.9%) |
| June 2005 | - | $1.06 B(-38.8%) | $5.68 B(-4.7%) |
| Mar 2005 | - | $1.74 B(+51.9%) | $5.96 B(+16.2%) |
| Dec 2004 | $5.13 B(+2.3%) | $1.14 B(-34.4%) | $5.13 B(+1.4%) |
| Sept 2004 | - | $1.74 B(+29.9%) | $5.05 B(+3.5%) |
| June 2004 | - | $1.34 B(+48.4%) | $4.88 B(+11.6%) |
| Mar 2004 | - | $903.00 M(-15.5%) | $4.37 B(-12.7%) |
| Dec 2003 | $5.01 B(+23.1%) | $1.07 B(-31.8%) | $5.01 B(+27.1%) |
| Sept 2003 | - | $1.57 B(+87.9%) | $3.94 B(+66.0%) |
| June 2003 | - | $834.00 M(-45.8%) | $2.37 B(+54.2%) |
| Mar 2003 | - | $1.54 B | $1.54 B |
| Dec 2002 | $4.07 B(+36.7%) | - | - |
| Dec 2001 | $2.98 B(-23.2%) | - | - |
| Dec 2000 | $3.88 B(+11.9%) | - | - |
| Dec 1999 | $3.47 B(+11.6%) | - | - |
| Dec 1998 | $3.11 B | - | - |
FAQ
- What is Novartis AG annual free cash flow?
- What is the all time high annual FCF for Novartis AG?
- What is Novartis AG annual FCF year-on-year change?
- What is Novartis AG quarterly free cash flow?
- What is the all time high quarterly FCF for Novartis AG?
- What is Novartis AG quarterly FCF year-on-year change?
- What is Novartis AG TTM free cash flow?
- What is the all time high TTM FCF for Novartis AG?
- What is Novartis AG TTM FCF year-on-year change?
What is Novartis AG annual free cash flow?
The current annual FCF of NVS is $11.71 B
What is the all time high annual FCF for Novartis AG?
Novartis AG all-time high annual free cash flow is $12.52 B
What is Novartis AG annual FCF year-on-year change?
Over the past year, NVS annual free cash flow has changed by -$292.00 M (-2.43%)
What is Novartis AG quarterly free cash flow?
The current quarterly FCF of NVS is $5.49 B
What is the all time high quarterly FCF for Novartis AG?
Novartis AG all-time high quarterly free cash flow is $9.54 B
What is Novartis AG quarterly FCF year-on-year change?
Over the past year, NVS quarterly free cash flow has changed by +$792.00 M (+16.87%)
What is Novartis AG TTM free cash flow?
The current TTM FCF of NVS is $12.51 B
What is the all time high TTM FCF for Novartis AG?
Novartis AG all-time high TTM free cash flow is $13.78 B
What is Novartis AG TTM FCF year-on-year change?
Over the past year, NVS TTM free cash flow has changed by -$1.05 B (-7.72%)